Medical Director, Global Medical Strategy (Rheumatology & Dermatology Pipeline)

The Medical Director, Global Medical Strategy (Rheumatology & Dermatology Pipeline) is a critical role responsible for shaping the strategic processes and planning for assets in early development (pre-Phase 3) within the Nephrology and Immunology portfolio.  This position manages the unique challenge of establishing an emerging portfolio, incorporating newly acquired assets, which requires significant scientific and strategic agility and a strong ability to balance competing priorities.  This position reports directly to the Senior Medical Director, Global Medical Strategy Franchise Lead.

Key Responsibilities Include:  

Medical Strategy & Narrative  

• Provide key medical input into the initial development of the Target Reimbursable Product Profile as well as early development plans ensuring scientific consistency and alignment across R&D, Clinical, Global Medical Affairs, and Early Commercialization functions   

• Provide high-quality scientific/clinical input and review of early asset plans, ensuring content aligns with the overarching Medical Narrative  

• Serve as a primary scientific resource, providing guidance on the disease state and mechanism of action for the early Nephrology and Immunology portfolio helping to translate science into value for patients and stakeholders  

• Lead the Strategy and Tactical Planning Process, identifying critical data needs for the emerging portfolio  

Evidence Generation Process  

• Oversee the Medical Evidence Generation Process, translating strategic data gaps into clear research priorities and providing expert input into the design and feasibility of clinical trials and data generation initiatives  

• Support the planning and execution of Medical Affairs evidence generation activities relevant to early assets  

External Stakeholder Engagement  

• Identify and engage KOL experts to support collection, curation and communication of clinical Medical and methodological insights to inform understanding of unmet medical needs, emerging standard of care and development opportunities  

• Develop Key Intelligence Topics & Questions (KITs/KIQs) for relevant assets, serving as the blueprint for insight collection from Key Opinion Leaders  

• Lead the strategic planning, content development, and successful facilitation of consulting activities including Advisory Boards, ensuring objectives align with data gap analyses and asset/portfolio strategy  

• Lead scientific exchange with key opinion leaders (KOLs) to gather insights and validate development hypotheses  

• Support the development of scientific publications, abstracts, and presentations related to early assets  

Cross-functional Integration & Planning  

• Collaborate within the Nephrology & Immunology Medical Business Unit with the Nephrology & Immunology Medical Communications and Field Medical Affairs sub-teams  

• Partner with and serve as a scientific and clinical resource for cross-functional colleagues including Clinical Development, Global Integrated Evidence & Innovation, Regulatory and Global Marketing and Market Access  

• Support indication prioritization and portfolio planning for early assets  

• Consider technology and AI to support workflow improvement  

Qualifications  

Education and Experience:  

• Advanced scientific degree required (PharmD, MD, PhD, or equivalent) with expertise in Rheumatology &/or Dermatology  

• 5+ years of relevant experience in the pharmaceutical industry, with strong preference for experience in Clinical Development, Research, or early-stage Medical Affairs  

• Expertise in Rheumatology &/or Dermatology is strongly preferred  

• Experience supporting BD evaluations for potential acquisitions  

• Experience contributing to the integration and strategic planning for newly acquired or in-licensed assets  

• Proven experience managing Evidence Generation processes and executing scientific Advisory Boards  

Skills and Competencies:  

• Motivated and solution-oriented with the ability to work collaboratively across the organization, particularly with R&D and Clinical teams  

• Strategic agility required to build and adapt scientific strategy for an emerging portfolio  

• Excellent communication and interpersonal skills, including experience presenting complex development strategies to large internal groups and engaging a limited number of highly specialized external experts  

• Full understanding o